Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
- PMID: 27376798
- DOI: 10.1007/s11596-016-1586-7
Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis
Abstract
Hypoxia-inducible factor-1 alpha (HIF-1α) plays a vital role in the initiation, evaluation and prognosis in lung cancer. The prognostic value of HIF-1α reported in diverse study remains disputable. Accordingly, a meta-analysis was implemented to further understand the prognostic role of HIF-1α in lung cancer. The relationship between HIF-1α and the clinicopathological characteristics and prognosis of lung cancer were investigated by a meta-analysis. PubMed and Embase were searched from their inception to January 2015 for observational studies. Fixed-effects or random-effects meta-analyses were used to calculate odds ratios and 95% confidence intervals of different comparisons. A total of 20 studies met the criteria. The results showed that HIF-1α expression in lung cancer tissues was significantly higher than that in normal lung tissues. Expression of HIF-1α in patients with squamous cell carcinoma was significantly higher than that of patients with adenocarcinomas. Similarly, non-small cell lung cancer (NSCLC) patients had higher HIF-1α expression than small cell lung cancer (SCLC) patients. Moreover, lymph node metastasized tissues had higher HIF-1α expression than non-lymph node metastasized tissues. A high level HIF-1α expression was well correlated with the expression of vascular endothelial growth factor and epidermal growth factor receptor in the NSCLC. Notably, NSCLC or SCLC patients with positive HIF-1α expression in tumor tissues had lower overall survival rate than patients with negative HIF-1α expression. It was suggested that HIF-1α expression may be a prognostic biomarker and a potential therapeutic target for lung cancer.
Keywords: epidermal growth factor receptor; hypoxia-inducible factor-1 alpha; non-small cell lung cancer; small cell lung cancer; vascular endothelial growth factor.
Similar articles
-
The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.Swiss Med Wkly. 2013 Sep 6;143:w13855. doi: 10.4414/smw.2013.13855. eCollection 2013. Swiss Med Wkly. 2013. PMID: 24018850 Review.
-
Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.J Thorac Oncol. 2009 Mar;4(3):284-90. doi: 10.1097/JTO.0b013e31819852d5. J Thorac Oncol. 2009. PMID: 19190516
-
[Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].Med Clin (Barc). 2014 May 20;142(10):432-7. doi: 10.1016/j.medcli.2013.02.040. Epub 2013 Aug 12. Med Clin (Barc). 2014. PMID: 23948151 Clinical Trial. Spanish.
-
Expression and significance of hypoxia inducible factor-1α and lysyl oxidase in non-small cell lung cancer.Asian Pac J Cancer Prev. 2013;14(6):3613-8. doi: 10.7314/apjcp.2013.14.6.3613. Asian Pac J Cancer Prev. 2013. PMID: 23886154
-
Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.Thorax. 2009 Dec;64(12):1082-9. doi: 10.1136/thx.2009.115691. Epub 2009 Sep 23. Thorax. 2009. PMID: 19778933 Review.
Cited by
-
The lncRNA ZEB2-AS1 is upregulated in gastric cancer and affects cell proliferation and invasion via miR-143-5p/HIF-1α axis.Onco Targets Ther. 2019 Jan 18;12:657-667. doi: 10.2147/OTT.S175521. eCollection 2019. Onco Targets Ther. 2019. PMID: 30705594 Free PMC article.
-
The expression of hypoxia inducible factor-1 alpha in diffuse large B-cell lymphoma (DLBCL) patients: a cross-sectional study in Indonesia.Ann Med Surg (Lond). 2023 Aug 15;85(10):4780-4787. doi: 10.1097/MS9.0000000000001162. eCollection 2023 Oct. Ann Med Surg (Lond). 2023. PMID: 37811023 Free PMC article.
-
NF-κB in the Radiation Response of A549 Non-Small Cell Lung Cancer Cells to X-rays and Carbon Ions under Hypoxia.Int J Mol Sci. 2024 Apr 19;25(8):4495. doi: 10.3390/ijms25084495. Int J Mol Sci. 2024. PMID: 38674080 Free PMC article.
-
Are there any theranostic biomarkers in small cell lung carcinoma?J Thorac Dis. 2019 Jan;11(Suppl 1):S102-S112. doi: 10.21037/jtd.2018.12.14. J Thorac Dis. 2019. PMID: 30775033 Free PMC article. Review.
-
Co-expression of PD-L1 and HIF-1α predicts poor prognosis in Patients with Non-small Cell Lung Cancer after surgery.J Cancer. 2021 Feb 2;12(7):2065-2072. doi: 10.7150/jca.53119. eCollection 2021. J Cancer. 2021. PMID: 33754005 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous